![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
01 OrPha Swiss GmbH (2)
02 Orifarm AB (1)
03 UNITED THERAPEUTICS EUROPE Ltd (4)
04 United Therapeutics Europe Ltd (5)
05 United Therapeutics Europe, Ltd (3)
01 Treprostinil (10)
02 treprostinil (5)
01 INFUSIONSVÄTSKA, LÖSNING (5)
02 Infusion (2)
03 Infusion fluid, resolution (4)
04 Treprostinil 100Mg 20Ml 1 Units Parenteral Use (1)
05 Treprostinil 200Mg 20Ml 1 Units Parenteral Use (1)
06 Treprostinil 20Mg 20Ml 1 Units Parenteral Use (1)
07 Treprostinil 50Mg 20Ml 1 Units Parenteral Use (1)
01 Italy (4)
02 Norway (4)
03 Sweden (5)
04 Switzerland (2)
01 Remodulin (13)
02 Blank (2)